Febbo Phillip G.
SEC CIK 1649245 · EDGAR
BoughtSold
Most active insiders at VCYT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stapley Marc | CEO, Dir | — | $8.92M |
| 2 | JONES EVAN/ FA | Dir | — | $2.00M |
| 3 | Chambers Rebecca | CFO | — | $1.91M |
| 4 | McGuire Annie | SVP, GC | — | $1.80M |
| 5 | Wygant Jonathan | VP, CAO | — | $1.54M |
| 6 | EASTHAM KARIN | Dir | — | $1.49M |
| 7 | Febbo Phillip G. | Chief Scientific, Med Off | — | $1.35M |
| 8 | Leite John | Gbl Chief Commercial Off | — | $1.34M |
| 9 | EPSTEIN ROBERT S | Dir | — | $1.19M |
| 10 | Holstein Jens | Dir | — | $628.3K |
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-04 19:54 | 2026-09-02 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $44.88 | -3,639 | 146.2K | -2% | -$163.3K |
| MT | 2026-09-04 19:54 | 2026-09-04 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | S - Sale | $43.05 | -13.1K | 133.0K | -9% | -$564.4K |
| T | 2026-06-04 21:38 | 2026-06-02 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $47.80 | -3,730 | 149.8K | -2% | -$178.3K |
| M | 2026-03-10 | 2026-03-06 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | A - Grant | $0.00 | +36.2K | 146.9K | +33% | $0 |
| 2026-03-04 | 2026-03-02 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | S - Sale | $36.16 | -13.4K | 117.3K | -10% | -$485.4K | |
| 2026-03-04 | 2026-03-02 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $36.01 | -6,035 | 130.8K | -4% | -$217.3K | |
| 2026-03-02 | 2026-02-26 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $38.75 | -24.5K | 136.8K | -15% | -$948.8K | |
| 2026-03-02 | 2026-02-26 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | A - Grant | $0.00 | +71.8K | 161.3K | +80% | $0 | |
| 2025-12-04 | 2025-12-02 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $46.16 | -2,955 | 89.5K | -3% | -$136.4K | |
| 2025-10-07 | 2025-10-06 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | S - Sale | $36.02 | -8,349 | 92.4K | -8% | -$300.7K | |
| 2025-09-04 | 2025-09-02 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $30.11 | -2,955 | 100.8K | -3% | -$89.0K | |
| 2025-06-04 | 2025-06-02 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $26.74 | -2,955 | 103.7K | -3% | -$79.0K | |
| 2025-03-10 | 2025-03-06 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | A - Grant | $0.00 | +24.2K | 106.7K | +29% | $0 | |
| M | 2025-03-06 | 2025-03-04 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | S - Sale | $33.34 | -8,037 | 82.5K | -9% | -$268.0K |
| M | 2025-03-03 | 2025-02-27+ | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $34.12 | -22.4K | 97.3K | -19% | -$765.1K |
| 2025-03-03 | 2025-02-27 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | A - Grant | $0.00 | +30.6K | 113.0K | +37% | $0 | |
| 2024-12-06 | 2024-12-04 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | S - Sale | $44.09 | -3,934 | 82.4K | -5% | -$173.5K | |
| 2024-12-04 | 2024-12-02 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $44.12 | -6,738 | 86.3K | -7% | -$297.3K | |
| 2024-03-08 | 2024-03-06 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | A - Grant | $0.00 | +39.9K | 93.1K | +75% | $0 | |
| D | 2023-10-04 | 2023-10-02 | VCYT | VERACYTE, INC. | Febbo Phillip G. | Chief Scientific, Med Off | A - Grant | $0.00 | +53.2K | 53.2K | New | $0 |
| D | 2023-03-03 | 2023-03-01 | ILMN | ILLUMINA, INC. | Febbo Phillip G. | SVP Chief Medical Off | A - Grant | $0.00 | +7,556 | 14.8K | +105% | $0 |
| D | 2023-02-23 | 2023-02-21 | ILMN | ILLUMINA, INC. | Febbo Phillip G. | SVP Chief Medical Off | F - Tax | $202.84 | -1,245 | 7,230 | -15% | -$252.5K |
| D | 2023-02-23 | 2023-02-21 | ILMN | ILLUMINA, INC. | Febbo Phillip G. | SVP Chief Medical Off | M - OptEx | $0.00 | +3,522 | 8,475 | +71% | $0 |
| 2022-11-08 | 2022-11-05 | ILMN | ILLUMINA, INC. | Febbo Phillip G. | SVP Chief Medical Off | F - Tax | $217.19 | -821 | 4,953 | -14% | -$178.3K | |
| 2022-04-07 | 2022-04-05 | ILMN | ILLUMINA, INC. | Febbo Phillip G. | SVP Chief Medical Off | F - Tax | $363.84 | -131 | 7,762 | -2% | -$47.7K | |
| 2022-04-07 | 2022-04-06 | ILMN | ILLUMINA, INC. | Febbo Phillip G. | SVP Chief Medical Off | S - Sale | $360.01 | -1,988 | 5,774 | -26% | -$715.7K | |
| D | 2022-03-03 | 2022-03-01 | ILMN | ILLUMINA, INC. | Febbo Phillip G. | SVP Chief Medical Off | A - Grant | $0.00 | +3,029 | 7,893 | +62% | $0 |
| D | 2022-02-24 | 2022-02-22 | ILMN | ILLUMINA, INC. | Febbo Phillip G. | SVP Chief Medical Off | M - OptEx | $0.00 | +2,851 | 5,866 | +95% | $0 |
| D | 2022-02-24 | 2022-02-22 | ILMN | ILLUMINA, INC. | Febbo Phillip G. | SVP Chief Medical Off | F - Tax | $319.86 | -1,002 | 4,864 | -17% | -$320.5K |
| 2021-11-09 | 2021-11-08 | ILMN | ILLUMINA, INC. | Febbo Phillip G. | SVP Chief Medical Off | S - Sale | $406.83 | -1,000 | 3,015 | -25% | -$406.8K | |
| 2021-11-09 | 2021-11-05 | ILMN | ILLUMINA, INC. | Febbo Phillip G. | SVP Chief Medical Off | F - Tax | $408.14 | -446 | 4,015 | -10% | -$182.0K |
Purchase Sale Sale after option exercise All abbreviations